Screener
Jazz Pharmaceuticals JAZZ Long-term investments
Long-term investments at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Investments.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
FAQ
- What is Jazz Pharmaceuticals's long-term investments?
- Jazz Pharmaceuticals (JAZZ) reported long-term investments of $1.03B in Q1 2026.
- How has Jazz Pharmaceuticals's long-term investments changed year-over-year?
- Jazz Pharmaceuticals's long-term investments increased by 45.1% year-over-year, from $710M to $1.03B.
- What is the long-term trend for Jazz Pharmaceuticals's long-term investments?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's long-term investments has grown at a -0.5% compound annual growth rate (CAGR), from $1.08B to $1.05B.
- What does long-term investments mean?
- Equity investments, venture capital, strategic stakes, and other investments with holding periods expected to exceed one year.
Ask your AI about Jazz Pharmaceuticals's long-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude